Lansen is a pharmaceutical group principally engaged in the production and sale of prescription pharmaceuticals for the treatment of autoimmune rheumatic diseases in the PRC. IMS Health estimates the PRC healthcare sector will be the second largest in the world in 2016, and the largest by 2050. The growth is being fuelled by the continuing government reforms to expand the national healthcare coverage system, and an increase in disease prevalence as a result of aging populations and effects linked to modern life. Lansen is the market leader in China’s disease modifying anti-rheumatic drugs (“DMARDs”) market capturing a share of more than 25% of the market. Rheumatoid arthritis (“RA”) is a chronic disease with the 4th highest prevalence rate after hypertension, gastroenteritis, and diabetes which indicates the strong and growing demand for RA treatment. Lansen owns and operates modern manufacturing facilities occupying approximately 71,000 square meters of land with total gross floor area of approximately 36,000 square meters located in Ningbo, PRC. These facilities are GMP certified by the State Food and Drug Administration and adhere to stringent and closely monitored quality assurance and safety control process. Lansen has expanded its specialty drug portfolio for the treatment of autoimmune disorders in rheumatologic indications to include dermatologic indications. Lansen acquired Sicorten Plus, a corticosteroid cream marketed and sold in China for dermatologic indications, from Novartis; and obtained the exclusive distribution rights for Kefumei, a collagen dressing product used in medical skincare, from Shaanxi Biogene Technology Co., Ltd. Lansen successfully listed on the main board of the Hong Kong Stock Exchange in 2010, raising a total of HKD611 million (USD78 million). Lansen continues to hold a market leading position in the rheumatology therapeutic area and is a major earnings contributor for the Group. Lansen Pharmaceutical Holdings Limited Address: Room 1804, 18/F, Cai Wuwei Jinlong Building, Luohu District, Shenzhen, 518001 People's Republic of China Telephone: +86 755 8207 6777 Fax: +86 755 8207 4000 Website: http://www.lansen.com.cn/en/index.aspx Cathay International Holdings Limited. Copyright © 2010. All right reserved. Disclaimer

The 5-star Hotel is located in the Luohu district of Shenzhen in the PRC. It is managed by the InterContinental Hotels Group, branded under Crowne Plaza Hotel & Suites. The Hotel has 312 enlarged superior rooms and suites, enhanced banquet and meeting facilities and a unique butler service for suite guests, which consistently achieved high customer satisfaction and was frequently rated by Tripadvisor as one of the top 10 hotels in Shenzhen. We expect the Hotel to steadily benefit from the economic growth in China and greater market awareness. Crowne Plaza Hotel & Suites Landmark Shenzhen Address: 3018 Nanhu Road, Shenzhen, 518001, People's Republic of China Telephone: +86 755 8217 2288 Fax: +86 755 8229 0479 Email: sm@szlandmark.com.cn Website: http://www.szlandmark.com.cn/ Cathay International Holdings Limited. Copyright © 2010. All right reserved. Disclaimer